The Trump administration continued to reshape U.S. health policy in recent days with several moves that could change what vaccines people can get to protect themselves from common illnesses.
Some of the changes are immediate, others are still being discussed, and must still sign off on some.
Doctors’ groups have expressed alarm at the moves made by Kennedy, a longtime anti-vaccine activist, and his appointees, who at times have ignored well-established science. Nearly 80 medical groups, including the American Medical Association, issued a statement backing vaccines against common respiratory ailments as “among the best tools to protect the public.”
“We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines,” the groups wrote.
Here’s what to know about some of the recent vaccine policy changes:
Flu shots and thimerosal
On Thursday, a vaccine advisory group handpicked by Kennedy recommended that just about every American get a flu shot this fall.
But the group also said people should avoid shots containing thimerosal, a preservative used only in large multi-dose vials . The ingredient isn’t used in single-dose flu shots, the type of syringe used for about 95% of U.S. flu shots last season.
Status: Kennedy must sign off on the recommendations. Read more .
How to get a COVID-19 shot
Universal access to updated shots for the fall remains unclear, even after Kennedy's vaccine advisers were shown data showing how well the vaccines are working.
Kennedy changed CDC guidance last month, saying the shots are no longer recommended for healthy children and pregnant women — even though doctors groups disagree. And the Food and Drug Administration has moved to limit COVID-19 vaccinations among healthy people under age 65.
Status: Upcoming advisory meetings, regulatory decisions and policies from insurers and employers are likely to influence access. Read more .
Expanded warnings on COVID-19 vaccine labels
At the request of the FDA, makers of the two leading COVID-19 vaccines on Wednesday expanded existing warnings about a rare heart side effect mainly seen in young men.
Prescribing information from both Pfizer and Moderna had already advised doctors about rare cases of myocarditis, a that is usually mild. The FDA had asked the drugmakers to add more detail about the problem and to cover a larger group of patients.
Status: Labels are being updated now. Read more .
Changes considered for the childhood vaccine schedule
On Wednesday, Kennedy’s vaccine advisers said they would be evaluating the “cumulative effect” of the — the list of immunizations given at different times throughout childhood.
The announcement reflected vaccine skeptics' messaging: that too many shots may overwhelm kids’ immune systems. Scientists say those claims have been repeatedly investigated with no signs of concern.
The American Academy of Pediatrics said it would continue publishing its own vaccine schedule for children but now will do so independently of the government advisory panel, calling it “no longer a credible process.”
Status: The examination is in its early stages. Read more .
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
